Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA)

Autor: Nikoletta Nikolenko, Darren G. Monckton, Michela Guglieri, Cecilia Jimenez-Moreno, Hanns Lochmüller, Giovanni DiPaolo, A. Atalaia
Jazyk: angličtina
Předmět:
Male
0301 basic medicine
Neurology
Myotonic dystrophy
Severity of Illness Index
0302 clinical medicine
Trinucleotide Repeats
Outcome Assessment
Health Care

Postural Balance
education.field_of_study
Original Communication
Age Factors
Middle Aged
Sensation Disorders
Falls
Female
DM1
medicine.symptom
Psychology
Natural history study
Balance
Adult
congenital
hereditary
and neonatal diseases and abnormalities

medicine.medical_specialty
Ataxia
Adolescent
Population
Clinical Neurology
Myotonin-Protein Kinase
Statistics
Nonparametric

Young Adult
03 medical and health sciences
Cronbach's alpha
Rating scale
medicine
Humans
Muscle Strength
education
Aged
Balance (ability)
Reproducibility of Results
medicine.disease
030104 developmental biology
Physical therapy
Accidental Falls
Neurology (clinical)
030217 neurology & neurosurgery
Zdroj: Journal of Neurology
ISSN: 0340-5354
DOI: 10.1007/s00415-017-8399-x
Popis: Myotonic dystrophy type 1 (DM1) is not characterised by ataxia per se; however, DM1 and ataxia patients show similar disturbances in movement coordination often experiencing walking and balance difficulties, although caused by different underlying pathologies. This study aims to investigate the use of a scale previously described for the assessment and rating of ataxia (SARA) with the hypothesis that it could have utility in DM1 patients as a measure of disease severity and risk of falling. Data from 54 DM1 patients were pulled from the PHENO-DM1 natural history study for analysis. Mean SARA score in the DM1 population was 5.45 relative to the maximum score of eight. A flooring effect (score 0) was observed in mild cases within the sample. Inter-rater and test–retest reliability was high with intraclass coefficients (ICC) of 0.983 and 1.00, respectively. Internal consistency was acceptable as indicated by a Cronbach’s alpha of 0.761. Component analysis revealed two principle components. SARA correlated with: (1) all measures of muscle function tested, including quantitative muscle testing of ankle dorsiflexion (r = −0.584*), the 6 min walk test (r = −0.739*), 10 m walk test (r = 0.741*), and the nine hole peg test (r = 0.602*) and (2) measures of disease severity/burden, such as MIRS (r = 0.718*), MDHI (r = 0.483*), and DM1-Activ (r = −0.749*) (*p
Databáze: OpenAIRE